IP
MLNT

Isthmus Partners’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Isthmus Partners’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,072
Closed -$7.66M – 210
2019
Q1 		$7.66M Buy
84,072
+81,072
+2,702% +$7.38M 1.86% 15
2018
Q4 		$12K Buy
+3,000
New +$12K ﹤0.01% 132